![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
GSK plc | NYSE:GSK | NYSE | Depository Receipt |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.11 | -0.27% | 39.90 | 40.005 | 39.49 | 39.97 | 4,916,752 | 22:16:55 |
By Sabela Ojea
Moncef Slaoui, who headed the Trump administration's Operation Warp Speed vaccine-development effort, has been fired from his position as chairman of Galvani Bioelectronics following an investigation into alleged sexual harassment and inappropriate conduct toward an employee.
Galvani's parent company, GlaxoSmithKline PLC, said Wednesday that Christopher Corsico, senior vicepresident development at GSK and a member of Galvani's board, will succeed Mr. Slaoui.
Mr. Slaoui wasn't immediately available for comment.
The British pharmaceutical giant said that it received a letter containing the allegations, which took place several years ago, and that it started an investigation with an experienced law firm.
The investigation has sustained the allegations and is still in progress, the FTSE 100-listed company said.
Shares in GlaxoSmithKline at 1328 GMT were down 14.60 pence, or 1.1%, at 1283.40 pence.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
March 24, 2021 09:55 ET (13:55 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year GSK Chart |
1 Month GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions